Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01974271
What this trial is testing

An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

Who this might be right for
Anemia
Hoffmann-La Roche 661
Testing effectiveness (Phase 2)Active Not RecruitingNCT04086264
What this trial is testing

IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
AbbVie 218
Testing effectiveness (Phase 2)Study completedNCT01109264
What this trial is testing

Bendamustine Hydrochloride Injection for Initial Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Jiangsu Simcere Pharmaceutical Co., Ltd. 147
Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Not applicableStudy completedNCT03875924
What this trial is testing

REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL)

Who this might be right for
Von Willebrand Diseases
Nantes University Hospital 926
Not applicableStudy completedNCT06659224
What this trial is testing

The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma

Who this might be right for
Acute Myeloid Leukemia (AML)Ewing Sarcoma
asmaa salama ibrahim 2,631
Testing effectiveness (Phase 2)Study completedNCT01151423
What this trial is testing

Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Ablynx, a Sanofi company 75
Testing effectiveness (Phase 2)Ended earlyNCT01646762
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Mayo Clinic 13
Not applicableStudy completedNCT04812873
What this trial is testing

Registry Study of ID & IDA in Korean Patients With Heart Failure

Who this might be right for
Iron Deficiency Anemia
JW Pharmaceutical 465
Early research (Phase 1)Looking for participantsNCT05857969
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+15 more
Florida International University 65
Not applicableLooking for participantsNCT06727669
What this trial is testing

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Who this might be right for
Immune ThrombocytopeniaThrombotic Thrombocytopenic PurpuraHemophilia A, Acquired+13 more
Peking University People's Hospital 3,000
Early research (Phase 1)Ended earlyNCT03761069
What this trial is testing

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Who this might be right for
Leukemia, Myeloid, AcuteAML
PTC Therapeutics 33
Not applicableStudy completedNCT02635217
What this trial is testing

Same Day Bidirectional Endoscopies - Does the Sequence of Procedures or Choice of Insufflator Matter?

Who this might be right for
AnemiaColon Polyps
Queen's University 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07588568
What this trial is testing

A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis

Who this might be right for
EoEEosinophilic EsophagitisEosinophilic Esophagitis (EoE)
University of North Carolina, Chapel Hill 52
Testing effectiveness (Phase 2)WithdrawnNCT02371590
What this trial is testing

Lenalidomide and Obinutuzumab for Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
University of California, San Diego
Not applicableNot Yet RecruitingNCT07597590
What this trial is testing

Digital Patient-Reported Assessment in Older Adults With Acute Leukemia

Who this might be right for
Leukemia Acute MyeloidLeukemia Acute Lymphoid Leukemia (ALL)
Fundación para la Investigación Biosanitaria del Principado de Asturias 20
Large-scale testing (Phase 3)Looking for participantsNCT06588413
What this trial is testing

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplantation
Augusta University 172
Not applicableStudy completedNCT04915820
What this trial is testing

Iron and COVID-19 Vaccine Response

Who this might be right for
Iron Deficiency AnemiaVaccine Response ImpairedCOVID-19 Vaccine+1 more
Jomo Kenyatta University of Agriculture and Technology 121
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Large-scale testing (Phase 3)Study completedNCT03444324
What this trial is testing

Adjusted Fibrinogen Replacement Strategy

Who this might be right for
Bleeding DisorderHypofibrinogenemia; Acquired
Biotest 222
Next Page